FDA WARNS J&J UNIT ON BLOOD-GLUCOSE TESTS

The Food and Drug Administration warned a unit of Johnson & Johnson for failing to properly investigate and report problems with blood-glucose tests used by people with diabetes. The warning letter, sent to Milpitas, Calif.-based LifeScan Inc., was posted Tuesday to the FDA's Web site.

Minneapolis Star Tribune (http://www.startribune.com/stories/535/5793602.html)